Financial statements Biotech Evolution
Balance sheet of Biotech Evolution
Company age:
Age:
4 y. 4 m. 15 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of BIOTECH EVOLUTION
|
Year
|
2021
|
2022
|
2023
|
|---|---|---|---|
| Total assets | 70 606,11 | 1 150 575,95 | 954 169,37 |
| A. Fixed assets | - | 0,00 | 42 524,67 |
| B. Current assets | 70 606,11 | 1 150 575,95 | 911 644,70 |
| C. Share capital contributions (basic funds) | - | 0,00 | 0,00 |
| D. Own shares (stocks) | - | 0,00 | 0,00 |
| Total liabilities | 70 606,11 | 1 150 575,95 | 954 169,37 |
| A. Equity | -579 902,36 | -1 645 466,59 | -1 500 069,87 |
| B. Liabilities and provisions for liabilities | 650 508,47 | 2 796 042,54 | 2 454 239,24 |
| I. Long-term liabilities | - | - | 230 639,79 |
| II. Short-term liabilities | - | - | 2 190 192,04 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.